Long-term Safety Study of GD2IL18CART Treatment

We are following up with patients who received GD2IL18CART to check for any long-term safety concerns and to see how well the treatment is working over time, especially in children.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Gd2il18cart

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Universitaetsklinikum Erlangen AöR
Medizinische Klinik 5 – Hämatologie und Internistische Onkologie
Erlangen, Germany
Universitaetsklinikum Erlangen AöR
Abteilung für Kinder- und Jugendmedizin
Erlangen, Germany
Universitaetsklinikum Essen AöR
Klinik für Hämatologie und Stammzelltransplantation
Essen, Germany

Sponsor: Universitaet Muenster
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.